The company said, “Excelerate is revising its full year 2025 Adjusted EBITDA guidance range. The Company now expects Adjusted EBITDA to range between $345 million and $365 million for the full year 2025. The full year Adjusted EBITDA guidance range reflects Excelerate’s standalone business only and excludes any anticipated contribution from the Pending Acquisition. Excluding any additional capital expenditures related to the Pending Acquisition, Excelerate reaffirms its previously announced guidance of Maintenance Capex and Committed Growth Capital for 2025 which are expected to range between $60 million and $70 million and $65 million and $75 million, respectively.”
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EE: